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Abstract
Introduction The prevalence of pain in patients with cancer
is still too high. Factors relating to ineffective pain
treatment fall into three categories: the health care system,
professional care providers, and patients. In patients,
various barriers lead to noncompliance. Previous educa-
tional interventions have increased their knowledge of pain
and decreased short-term pain levels. In this randomized
controlled trial, the authors investigated how an intensive
home-based education program given by nurses affected
short-term and long-term pain levels.
Materials and methods One hundred and twenty cancer
patients were randomized to receive either the pain
education program (PEP) or usual care. Pain, knowledge,
quality of life, anxiety, and depression were measured at
baseline and after 4 and 8 weeks. In the intervention group,
effects on symptom levels were communicated to the
treating physician.
Results The level of pain had decreased at 4 weeks, but not
at 8 weeks. Significant decreases in pain only persisted in
those patients with a high pain score at baseline. Knowl-
edge of pain significantly increased in the intervention
group. No correlation was found between increased pain
knowledge and decreased pain levels.
Conclusions The PEP given by nurses lowered pain inten-
sity levels in cancer patients and increased their knowledge
of pain. More attention should be paid to patient education
and to communication between patients and health profes-
sionals regarding pain and pain management.
Keywords Randomizedclinicaltrial.Paineducation
program.Canceroutpatients.Pain.Painmanagement
Introduction
Many cancer patients have (multiple) symptoms that can
affect their feeling of well-being as well as their physical
and social functioning. One of the most feared and
burdensome physical symptom in cancer patients is pain.
A recent review has shown that the prevalence of pain in
cancer patients is still high: 64% in patients with metastatic,
advanced, or terminal disease and 59% in patients on
anticancer treatment [1].
Factors relating to ineffective pain management fall into
three categories: the health care system, health care
providers, and patients [2]. In the health care system, more
attention is focused on “curing” cancer patients than on
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Health care providers tend to show a lack attention for and
knowledge about pain management [4–11]a n d ,a sa
consequence, do not always treat pain according the World
Health Organization guidelines [5, 10]. Patients generally
lack knowledge about pain and pain management and are
reluctant to report pain to their physician [11, 12]. Fears
such as drug addiction, tolerance, and concerns about side
effects also influence their intake of pain medication [6, 13–
16]. However, patients indicated that they would appreciate
help with their physical and psychosocial problems and
would like to receive information on this [17–19].
In the health care provider category, Goldberg and
Morison conducted a systematic review of institutional
interventions designed to improve the assessment and
treatment of pain in cancer patients [20]. This review
included three trials that studied the effects of education for
nurses on pain-related topics [21–23]. They concluded that
these education sessions improved nurses’ knowledge of
pain and their attitudes toward it [20]. However, these
interventions did not lead to any significant decrease in the
severity of pain in their patients [20]. None of the
randomized controlled trials (RCTs) specifically targeted
other health care providers or physicians.
In the present study, we focused on patient-related
factors in the knowledge and management of pain. A
review of 17 RCTs on pain and pain management education
for patients [24–40] suggested that tailored education
counseling sessions directed at patients improved pain
scores [24–26, 29–31, 33, 34, 37, 38, 40] and altered any
negative beliefs and misconceptions about pain [25, 26, 29,
30, 32, 33, 37, 39]. In 12 studies, pain education was
provided by nurses [24, 25, 27–29, 31–33, 35–37, 39]; in
two studies, pain education was provided by other health
care educators (e.g., research assistants, master students)
[26, 30]; in two other studies, this aspect was not mentioned
[34, 38]; and in the final study, a video was shown [40].
Although the results of the patient-related RCTs were
generally positive, there is still a need to gain more insight
into the efficacy of pain education programs (PEPs) [31].
There were methodological flaws in many areas in existing
RCTs. In most studies, only the short-term effects were
measured [25, 26, 28–31, 34, 38, 40]. It is not clear whether
short-term effects are sustained over longer periods of time.
The education programs were generally fairly light (e.g.,
one face-to-face education session or one session combined
with one or more telephone calls) [24–26, 32–35, 37–40],
while it is well-known that patients and their family care
providers require ongoing assistance with problem-solving
in order to optimize their pain management regimen [41].
Little is known about which subgroups gain the most from
PEPs. This knowledge is necessary in order to tailor
education programs and to maximize their effectiveness
[42]. Only one study indicated that the educational level of
patients might influence the effects of PEPs [43]. Only a
very small proportion of the studies incorporated variables
such as gender, age, and stage of the disease [32, 33]. None
of the studies mentioned incorporated pain scores at
baseline or anxiety and depression scores at baseline,
although depression and pain form a well-known cluster
[44] and depressive disorders can affect compliance [45].
The study population was small in almost half the RCTs
with less than 35 participants in the intervention and control
groups [26, 29, 30, 34–36, 40]. Attention was paid to
communication between the nurses who gave the education
and the treating physicians in only one study [25], although
continuity of care and communication between health care
providers is known to be of major importance in the pain
management process [43].
In the present study, we tried to avoid making any of
the above-mentioned methodological errors. Our aim was
to evaluate how an intensive home-based PEP given by
nurses affected the short-term and long-term effects of
levels of pain, pain knowledge, quality of life, anxiety,
and depression.
Materials and methods
Source population
Patients were recruited from two sources: Firstly, from our
previous prevalence study on pain and other symptoms in
the province of Limburg, situated in the south of The
Netherlands. The outpatients who scored 4 or higher on the
pain intensity scale (range 0–10, 10=worst pain) and who
gave their written consent to participate in the next research
project were asked to participate in this intervention study.
This resulted in 54 patients. Secondly, patients were
recruited by nurses and physicians working at outpatient
clinics and the radiotherapy department. This resulted in 65
patients. A total 120 patients were included.
Patients were eligible if (1) they had been diagnosed
with cancer, (2) they had been informed of their diagnosis,
(3) they were aged 18 years or more, (4) they were able to
understand and complete the questionnaire, (5) they had a
“present” pain score of 4 or higher on a scale of from 0 to
10, and (6) they had agreed to participate in the study.
Treatment stages included curative anticancer treatment,
palliative anticancer treatment, and no further treatment
options available. Patients were excluded if they had
completed their curative anticancer treatment before the
year 2000.
The study was approved by the Medical Ethics Com-
mittee of the University Hospital Maastricht. All the
participants gave written informed consent.
1090 Support Care Cancer (2009) 17:1089–1099Intervention
All patients were randomly allocated to the intervention
group (n=58) or the control group (n=62), based on a
computer-generated randomization procedure.
Patients in the control group received their usual care
from their treating physician. Patients in the intervention
group received specialized nursing care at home, at the
same time as the care received from their treating physician
(Fig. 1). This specialized care included the PEP and the
monitoring of symptoms other than pain.
The PEP was developed by De Wit et al. [37] and
consists of the following three components: (1) enhance-
ment of patients’ pain knowledge and pain management by
means of a brochure, (2) instruction of patients as to how
they should record their pain intensity in a pain diary, and
(3) stimulation of patients’ help-seeking behavior. An
extensive description of the PEP can be found in the article
in which it originally appeared [37]. In the intervention
group, palliative care nurses made three home visits, each
lasting 1–1.5 h.
The pain brochure provides information on the following
topics: possible causes of pain, pain control, nonadherence,
misconceptions, and various nonpharmacological pain
management techniques (cold, heat, relaxation, and mas-
sage). This brochure was tested in an earlier study [46].
First home visit
The first home visit took place within 1 week of the
baseline measurement. Intake data were recorded by the
nurses in order to tailor the PEP to the patient’s situation.
These data were connected with intensity of pain, location
of pain, type of pain, prescription of medication, adherence
to medication, emotional well-being, and other physical
symptoms. A pain brochure was handed to the patient and,
if possible, studied in the presence of a family caregiver.
Patients were invited to ask questions. They also received a
pain diary with a clear explanation on how to record their
pain intensity twice daily using a numerical rating scale
from 0 to 10. If any pain problems or other physical and
emotional symptoms arose, patients were encouraged to
contact their health care provider.
After the first visit, the nurses reported their findings to
the treating physician in writing. If necessary, advice was
given with regard to pain medication, in all cases in
consultation with a specialist in the pain treatment of
oncology patients. This advice consisted of starting new
pain medication, increasing the dosage of pain medication,
or changing to a different pain medication regimen and was
enclosed with their report.
Second home visit
During the second home visit, which took place in week 3,
the nurse reviewed the pain intensity scores in the pain
diary in order to detect any changes in pain intensity levels.
Any changes in type of pain, location of pain, prescription
of pain medication, or adherence to medication were also
reviewed. Patients were asked whether they had read the
“pain brochure” themselves and had fully understood all the
information. Care was taken to discuss anything that was
unclear to them in the brochure and/or to repeat relevant
information. If necessary, patients were encouraged to
contact their health care provider regarding their pain
problems and/or other symptoms.
Third home visit
The third and final home visit, which took place in week 6,
dealt with the same points as the second visit. Thereafter, the
nurse wrote to the treating physician regarding the patient’s
situation. If necessary, advice was given in connection with a
change in pain medication and enclosed with the report.
Measurements
Outcome measurements were assessed in both the inter-
vention and control groups at baseline (T0), week 4 (T1),
and week 8 (T2) (Table 1).
usual care control  T0  intervention T0 
week 1: home visit 1
week 3: home visit 2
week 4: follow-up 1 (T1)
week 6: home visit 3
week 8: follow-up 2 (T2)
week 4: follow-up 1 (T1) 
week 8: follow-up 2 (T2) 
Recruitment and randomization
Fig. 1 Study design
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ventions that targeted pain and other symptoms were
obtained from the medical records. Pain was measured
using four questions taken from the Brief Pain Inventory
(numerical rating scale) [47]. This has high internal
consistency with coefficient alphas ranging from 0.78 to
0.97 in various cancer population samples from different
countries [48–57]. The “present” pain score was chosen as
a primary outcome, since it is less subject to the biases that
affect recall measurements [58], and patient recall accuracy
depends, in part, on the stability of the pain [43].
Patients’ knowledge about pain was measured with a
translated version of Ferrell’s Pain Questionnaire [59, 60].
The questionnaire consists of eight items, including patients
are often given too much pain medication, most patients
become addicted to their medication over time, and it is
better to take pain medication around the clock (following a
schedule) than only when needed. All the scores were
converted linearly into a scale of from 0 to 100 (0=lowest
knowledge score, 100=highest knowledge score). PKQ-
DLV has demonstrated acceptable levels of validity and
reliability [43].
Quality of life and nonpain symptoms were measured
using EORTC-C30 version 3 [61]. EORTC-C30 is (1)
cancer-specific, (2) multidimensional, (3) suitable for self-
administration, and (4) applicable across a range of cultural
settings. It consists of five functional scales, three symptom
scales, a global health/quality of life scale, and six single
items. EORTC QLQ-C30 has shown acceptable levels of
validity and reliability [61].
Depression and anxiety were measured using the Dutch
version of the Hospital Anxiety and Depression Scale
(HADS) [62]. HADS performs well when assessing
symptom severity and caseness of anxiety disorders
(Cronbach’s α=0.68–0.93) and depression (Cronbach’s
α=0.67–0.90) in somatic, psychiatric, and primary care
patients with a sensitivity and specificity of approximately
0.80 [63].
Participation satisfaction with the intervention was
measured by asking patients the following questions: (1)
Would you like to continue following the PEP? (2) Would
you advise other patients to take part in the PEP? Response
options were “yes” or “no.”
Use of materials was evaluated at the end of the study by
asking patients whether they had used the pain diary and
the compact disc (CD) and read the information booklet.
Response options were “yes” or “no.”
Advice regarding a change in pain medication prescrip-
tion at T0, T1, and T2 was analyzed by comparing the
advice in the reports to the treating physician to the
patients’ reports about pain medication.
Statistics
A total of 80 patients were needed in order to ensure that
the main effects of the treatment group on pain intensity
could be tested adequately. Many patients would not able to
complete the study, either because they would become too
ill or would die. Therefore, 120 patients were recruited to
ensure that 80 would complete the study. The power
analysis conducted in this study was based on data from
an earlier study of the PEP [43]. It was necessary to have 40
patients in both the intervention and control groups in order
to obtain a clinically relevant difference of 1.5 points on a
ten-point scale with an alpha of 0.05, a beta of 0.20, and a
standard deviation (SD) of 2.4. Data were analyzed using
the Statistical Package for the Social Science version 12.
Descriptive statistics were used to evaluate the demograph-
ic variables, medical variables, pain, symptoms other than
pain, knowledge about pain and pain treatment, quality of
life, depression, and anxiety. At T0, comparability between
the intervention and control groups was analyzed using
independent Student’s t tests and chi-square tests.
Mixed regression models were used to evaluate the
longitudinal data on the effects of PEP and changes over
time. The high number of patients not completing this
study, mainly due to severe illness and death, led to an
unbalanced data set that could not be analyzed using
traditional methods, such as repeated-measures analysis of
variance. Mixed regression models offering an alternative
for dealing with unbalanced data sets can be found in the
literature [64]. Therefore, the changes in outcome measures
and pain over time were tested using the random intercept
model.
Results
A total of 120 patients were entered in the study (Fig. 2). At
T2, 83 of these patients had completed the follow-up. After
randomization, 13 patients were excluded (eight from the
Table 1 Study measurements at T0 (baseline), T1 (week 4), and T2
(week 8)
Outcome measures T0 T1 T2
Pain intensity + + +
Pain knowledge + +
Quality of life + + +
Anxiety and depression + +
Process variables (intervention group only)
Patient satisfaction +
Use of pain diary +
Use of CD +
Use of information booklet +
Medication prescription + + +
1092 Support Care Cancer (2009) 17:1089–1099control group, five from the intervention group) because
they did not meet the inclusion criteria: seven patients were
not suffering from cancer-related pain (arthritis, three cases;
osteoporosis, one case; rheumatic disease, one case; dialysis,
one case; and carpal tunnel syndrome, one case), four
patients had completed their curative treatment before
2000, and one was already familiar with the PEP brochure.
Data were missingatbaseline,T1,or T2in 27patients (ten in
the control group, 17 in the intervention group) (for further
details, see Fig. 2).
No significant differences were found in the demograph-
ic characteristics, treatment group, and baseline pain levels
between the intervention and control groups at baseline
(Table 2). Despite the randomization procedure, the
baseline level of pain knowledge was significantly better
in the control group than in the intervention group (p=
0.017). The lowest scores at baseline were observed for the
item “take the lowest dose of medication possible” in both
the intervention and control groups (16.9 and 27.7,
respectively). No significant differences were found in the
categories quality of life (except for role functioning) or
prevalence of other symptoms.
Changes in the level of pain, level of pain knowledge,
quality of life, anxiety, and depression
On short-term measurement (week 4), the intervention
group showed significant pain reduction (p=0.02) com-
pared to the control group (Fig. 3a). No significant (p=
0.14) long-term effect was seen (Table 3).
The level of pain knowledge was measured at baseline
(T0) and after 8 weeks (T2). At week 8, the level of pain
knowledge was significantly better in the intervention
group (p<0.00) than in the control group (Fig. 3b).
Significant improvement was seen for the items “take the
lowest dose of medication possible”, “use of routine
Allocated to control group 
N=62 
Allocated to intervention 
group  N=58 
N=47 completed baseline 
N=15 did not complete 
baseline (T0) 
Reasons: 
N=8 excluded 
N=4 too ill 
N=3 died before baseline 
measurement 
N=45completed baseline 
N=13 did not complete 
baseline (T0) 
Reasons: 
N=5 excluded 
 
N=3 * missed baseline  
measurement but 
completed follow-up 1 & 2 
N=2 too ill 
N=2 died before baseline 
measurement 
N=1 refused to participate 
 
 
 
N=45 completed follow-up 1 
 
N=2 did not complete 
follow-up 1 (T1) 
Reason: 
refused to participate 
N=38 + N=3 *   N=41 
completed follow-up 1 
 
(*N=3 missed baseline, but 
completed follow-up 1 and 2) 
N=7 did not complete 
follow-up 1 (T1) 
Reasons: 
N=2 too ill 
N=2 died 
N=3 refused to participate.  
N=44 completed follow-up 2  N=39 completed follow-up 2
N=1 did not complete 
follow-up 2 (T2) 
Reason: too ill 
N=2 did not complete 
follow-up 2 (T2) 
Reason: too ill 
Total randomised 
N=120
Fig. 2 Flowchart of participants
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addicted” in the intervention group. Levels of pain
knowledge did not improve in the control group (Table 4).
No correlation was found between the increase in pain
knowledge and the change in “present” pain scores
(Pearson correlation=0.03, p=0.860). Quality of life did
not show any significant effects over time.
Factors relating to short-term and long-term changes in pain
scores
The “present” pain intensity at baseline had a significant
influence on the “present” pain intensity on short-term and
long-term measurement (Fig. 4). There were no differences
in pain scores at T1 (week 4) and T2 (week 8) between the
intervention and control groups in patients with a baseline
pain score of 1–3. At T1, pain was significantly lower in
the intervention than in the control group (p=0.02) in
patients with a baseline pain score of 4–6. However, this
difference had disappeared at T2 (p=0.13). Significant
differences in pain were found between the intervention and
control groups at T1 (p=0.00) and T2 (p=0.00) in patients
with a baseline score of 7–10.
Neither gender, age, education level, severity of illness,
nor baseline levels of anxiety and depression had a
significant influence on the “present” pain intensity levels
in either the intervention or the control group.
Adherence to advice about medication from treating
physicians
After the first and third home visits, the nurse reported in
writing to the treating physician regarding the patient’s pain
problems (intensity, location, and type). In 37 cases, this
report included advice in connection with a change in the
pain medication regimen. In 22 of these cases, this advice
was ignored. In eight cases, it was unclear whether this
advice had been taken or not.
Patient opinion regarding the pain education program
When patients with complete data sets (29 cases) were
asked whether they would like to continue with the PEP,
Table 2 Baseline characteristics in the intervention group and the
control group
Intervention group Control group p value
Age (years)
Mean (SD) 62.0 (10.3) 60.5 (10.0) NS
Gender (%)
Men 52.1 38.3 NS
Women 47.9 61.7 NS
Education (%)
Primary school 77.1 70.2 NS
Secondary school 6.3 4.3 NS
College/university 10.4 23.4 NS
Missing 6.3 2.1 NS
Treatment group (%)
Group 1 20.8 27.7 NS
Group 2 58.3 53.2 NS
Group 3 18.8 17.0 NS
Missing 2.1 2.1 NS
Baseline pain
a 4.43 4.71 NS
Pain knowledge 52.8 59.5 0.017
Group 1 patient is currently under curative anticancer treatment or this
treatment has finished (<5 years), Group 2 patient is currently under
palliative anticancer treatment or this is a treatment option, Group 3
no further treatment options available
aPresent pain
* p=0.02 
*
1 p=0.017
    *2 p < 0.00 
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Fig. 3 Changes in the level of pain and the level of pain knowledge in
the intervention and the control group over time. a Changes in
“present” pain over time. *p=0.02. b Change of knowledge over time.
*
1p=0.017; *
2p<0.00
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support from the specialized nurse. The most important
reasons for this were support and having someone
available to answer questions on pain medication. The
patients who did not wish continue reported that the three
sessions had been enough for them to be able to follow
the information on pain and pain medication. When asked
whether they would advise other patients with pain
complaints to take part in the PEP, all patients replied
that they would. Patients’ response to the third question in
the pain brochure, the pain diary, and the educational CD
revealed that 73% had read the pain brochure and used
the pain diary.
Discussion
In this RCT, an intensive pain intervention program
presented by nurses resulted in short-term pain reduction
in patients with moderate pain at baseline and in long-term
pain reduction in patients with severe pain at baseline. The
intervention improved patients’ knowledge of pain and pain
medication. Furthermore, patients were satisfied with the
intervention and would recommend it to others.
In most RCTs on educational interventions in patients,
pain reduction was noted in the short-term (1 to 4 weeks)
[24–26, 29, 30, 33, 34, 37, 38, 40]. These interventions
differed greatly in type and intensity, ranging from showing
a video [40], having a single face-to-face meeting [25, 26,
34, 38], setting up a combination of one to three face-to-
face meetings and one or more telephone consultations [24,
30, 33, 36], to conducting five face-to-face meetings over 5
days [29]. However, not all the results of the short-term
studies were positive [28, 31, 35, 39].
Far fewer studies focused on the long-term effects. The
majority did not see any long-term (6 weeks to 6 months)
effects on pain intensity [24, 33, 35, 36, 39]. However, one
study showed improvement [27] and two reported long-
term pain reduction [31, 37]. The interventions used also
differed widely in type and intensity.
The intensity of an intervention is apparently not the
only effective component of a PEP, since neither the type
nor the intensity could predict a positive outcome. In our
study, patients with more severe pain at baseline (visual
analog scale [VAS] scores of 7–10) achieved most benefit
Table 3 Mean “present” pain scores in the intervention group and the
control group at baseline (T0), week 4 (T1), and week 8 (T2)
“Present” pain p value
Intervention group Control group
Mean (SD) Mean (SD)
T0 4.71 (2.21) 4.43 (2.33) 0.72
T1 (week 4) 3.78 (2.63) 4.84 (2.62) 0.02
T2 (week 8) 4.00 (2.17) 4.62 (2.25) 0.14
Table 4 Mean scores on level of pain knowledge in the intervention
group and control group at baseline (T0) and week 8 (T2)
Level of Pain Knowledge p value
Intervention group Control group
Mean (SD) Mean (SD)
TO 52.85 (12.96) 59.51 (13.64) 0.017
T2 (week 8) 63.30 (13.10) 57.05 (15.39) <0.00
changes in "present" pain over time in subgroups according to baseline pain
in the intervention group
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T1 (week 4)
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b
Fig. 4 Changes in “present” pain over time in three subgroups
according to baseline pain (mild, moderate, and severe baseline pain).
a Changes in “present” pain over time in subgroups according to
baseline pain in the intervention group. b Changes in “present” pain
overtime in subgroups according to baseline in the control group
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In neither the intervention nor the control group did we find
that gender, age, education level, severity of illness, or
baseline levels of anxiety and depression significantly
influenced the “present” pain intensity levels. None of the
other articles studied were suitable for comparison pur-
poses. Only one study mentioned that demographic
parameters did not greatly affect the impact of the
intervention, but it was unclear what these authors, in fact,
meant [32]. Another study classified the population
according to race and found a positive short-term effect in
African Americans, but not in Hispanics [24].
Apart from better patient selection, other possible factors
for improving the long-term effectiveness of an intervention
are (1) the close involvement of family caregivers in the
education program [31, 37] and (2) direct feedback from
the nurse to the treating physician on pain levels and other
problems. Aubin’s study [25] was the only other one in
which the nurses directly communicated the results of the
intervention to the patient’s treating physician. However, it
was unclear how they reported the results to the treating
physicians and whether this had any effect. In our study, the
specialized nurses wrote to the treating physicians with
details of the patients’ pain levels, other symptoms, and
further observations. If a patient had rated their pain as
VAS>4, the report also advised the physician to change the
pain medication regimen. The contents of the advice were
formulated in cooperation with a physician from the
palliative care team and according to the Dutch guidelines
for pain management [65]. We observed that much of the
advice was not followed, suggesting that this means of
communication was inadequate. Possible explanations
could be that the report was stored unread in the patient’s
medical file, too much time had elapsed between receiving
the report and actual patient–physician contact, or reluc-
tance from the physicians to follow uninvited advice.
Another explanation could be insufficient involvement of
the treating physicians in the implementation of the
intervention. Future comparable research projects might
benefit from closer communication with the treating
physician. Support for this argument can be found in the
study by Vallieres [34]. Direct access to a physician who
could adjust the analgesic regimen formed part of the
intervention. Patients were clearly instructed when (at what
pain level, or after three rescue doses in 24 h) to contact
their doctor. In addition, they were asked to bring their pain
diary with them to the consultation, to help the doctor
adjust the analgesic regimen, and also to improve commu-
nication between the patient and the doctor. Although the
study sample was small, the results seem to be promising.
Unfortunately, no long-term effects have been reported
[34]. In all the above-mentioned RCTs, part of the
education program was to encourage patients to talk to
their treating physician about their pain. However, no data
are available on the effects of patient education on
communication with treating physicians.
In agreement with most of the other RCTs, our study
showed an increase in pain knowledge following the
intervention. In one trial, only the informal caregiver
improved his knowledge [36], whereas in two trials, there
was no effect on pain knowledge [35, 39]. The rationale
behind PEPs for patients is based on the presumption that
better-educated patients will adhere better to their medica-
tion regimen and communicate more adequately with their
treating physician. In our study, no correlation was found
between an increase in pain knowledge and a decrease in
pain level. In the field of cardiology, it was shown that
patient education led to significantly lower levels of low-
density lipoprotein cholesterol in high-risk patients (n=
3,053) [66] and to significantly fewer admissions for heart
failure [67]. Three studies confirmed that fewer barriers
(e.g., less fear of addiction and tolerance and a better sense
of control) led to better adherence to pain medication [26,
30, 31]. In contrast, two other studies found no correlation
between decreases in barriers and pain levels [33, 69]. A
further study (n=342) showed that patients’ beliefs were
not associated with reports about pain or adherence to
medication [68]. Interventions should probably have a
multifaceted design that not only incorporates education
on various disease-related topics, but also implements
strategies for changing patient behavior [69].
Limitations
Our study population knew that they were enrolled in pain
research, which may have stimulated both the intervention
and the control group to talk about their pain with their
treating physicians or other health care providers and
diminished the distinction between the two groups. Another
factor that might have affected comparability between the
intervention and control groups is the severe illness in the
patient population and the inherent inability to control
disease progression.
Written communication with the treating physicians
proved to be inadequate. Future research should include a
more direct means of communication.
Recommendations
We recommend that researchers consider the following
components in future education programs due to their
potential ability to reduce pain levels in the longer-term: (1)
Involve the patient and family caregivers as much as
possible [31, 42]. (2) Communicate with the patient by
1096 Support Care Cancer (2009) 17:1089–1099telephone to reinforce the information and to monitor pain
[27, 31, 42]. (3) Integrate medical care into the nursing-
based education program, i.e., direct contact between the
nurse and the physician who can adjust the analgesic
regimen. (4) Formulate clear instructions as to how and
when to contact the doctor [34]. (5) Have the patients keep
a pain diary and let them refer to it during communication
with their health care providers [34].
Further research is needed to test the efficacy of the
separate components and to establish the most effective
intensity of PEPs. In order to investigate the exact
mechanism of how pain levels can be reduced in the
longer-term, we recommend that studies measure not only
knowledge, pain, symptoms, and quality of life, but also the
pain medication regimen [34], medication adherence (e.g.,
by using a pillbox) [31], and communication between the
patients and their physicians.
Conclusions
This study showed that a PEP presented by nurses could
lower pain intensity in cancer patients. Patients with higher
pain scores benefited more from the intervention, and the
effects lasted longer.
Our results support those of earlier studies in which
nurses gave pain education to patients and increased their
knowledge of pain. However, no correlation was found
between an increase in pain knowledge and a decrease in
pain level. As well as educating patients, more attention
should be paid to the communication between patients and
professional care providers on pain and pain management.
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